These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22065949)

  • 1. ROCKing Regeneration: Rho Kinase Inhibition as Molecular Target for Neurorestoration.
    Tönges L; Koch JC; Bähr M; Lingor P
    Front Mol Neurosci; 2011; 4():39. PubMed ID: 22065949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ROCK inhibition and CNTF interact on intrinsic signalling pathways and differentially regulate survival and regeneration in retinal ganglion cells.
    Lingor P; Tönges L; Pieper N; Bermel C; Barski E; Planchamp V; Bähr M
    Brain; 2008 Jan; 131(Pt 1):250-63. PubMed ID: 18063589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rho/ROCK pathway and neural regeneration: a potential therapeutic target for central nervous system and optic nerve damage.
    Tan HB; Zhong YS; Cheng Y; Shen X
    Int J Ophthalmol; 2011; 4(6):652-7. PubMed ID: 22553739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic effects of Rho-ROCK inhibitors on CNS disorders.
    Kubo T; Yamaguchi A; Iwata N; Yamashita T
    Ther Clin Risk Manag; 2008 Jun; 4(3):605-15. PubMed ID: 18827856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced neurite outgrowth of human model (NT2) neurons by small-molecule inhibitors of Rho/ROCK signaling.
    Roloff F; Scheiblich H; Dewitz C; Dempewolf S; Stern M; Bicker G
    PLoS One; 2015; 10(2):e0118536. PubMed ID: 25714396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Rho kinase pathway in chondroitin sulfate proteoglycan-mediated inhibition of neurite outgrowth in PC12 cells.
    Gopalakrishnan SM; Teusch N; Imhof C; Bakker MH; Schurdak M; Burns DJ; Warrior U
    J Neurosci Res; 2008 Aug; 86(10):2214-26. PubMed ID: 18438921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho-ROCK inhibition in the treatment of spinal cord injury.
    Forgione N; Fehlings MG
    World Neurosurg; 2014; 82(3-4):e535-9. PubMed ID: 23298675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho-kinase (ROCK) Inhibitors - A Neuroprotective Therapeutic Paradigm with a Focus on Ocular Utility.
    Abbhi V; Piplani P
    Curr Med Chem; 2020; 27(14):2222-2256. PubMed ID: 30378487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROCK inhibition promotes adult retinal ganglion cell neurite outgrowth only in the presence of growth promoting factors.
    Ahmed Z; Berry M; Logan A
    Mol Cell Neurosci; 2009 Oct; 42(2):128-33. PubMed ID: 19524675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of nerve growth factor-induced neurite outgrowth by the ROCK inhibitor Y-27632: a possible role of IP₃ receptors.
    Minase T; Ishima T; Itoh K; Hashimoto K
    Eur J Pharmacol; 2010 Dec; 648(1-3):67-73. PubMed ID: 20854802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo.
    Lingor P; Teusch N; Schwarz K; Mueller R; Mack H; Bähr M; Mueller BK
    J Neurochem; 2007 Oct; 103(1):181-9. PubMed ID: 17608642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho-ROCK inhibitors for the treatment of CNS injury.
    Kubo T; Yamashita T
    Recent Pat CNS Drug Discov; 2007 Nov; 2(3):173-9. PubMed ID: 18221230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-ganglioside antibody-mediated activation of RhoA induces inhibition of neurite outgrowth.
    Zhang G; Lehmann HC; Manoharan S; Hashmi M; Shim S; Ming GL; Schnaar RL; Lopez PH; Bogdanova N; Sheikh KA
    J Neurosci; 2011 Feb; 31(5):1664-75. PubMed ID: 21289175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROCK in CNS: Different Roles of Isoforms and Therapeutic Target for Neurodegenerative Disorders.
    Chong CM; Ai N; Lee SM
    Curr Drug Targets; 2017; 18(4):455-462. PubMed ID: 27033194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CRMP4 as a convergent regulator of axon outgrowth inhibition.
    Alabed YZ; Pool M; Ong Tone S; Fournier AE
    J Neurosci; 2007 Feb; 27(7):1702-11. PubMed ID: 17301178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho-ROCK inhibitors as emerging strategies to promote nerve regeneration.
    Kubo T; Hata K; Yamaguchi A; Yamashita T
    Curr Pharm Des; 2007; 13(24):2493-9. PubMed ID: 17692017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rho-independent stimulation of axon outgrowth and activation of the ERK and Akt signaling pathways by C3 transferase in sensory neurons.
    Auer M; Schweigreiter R; Hausott B; Thongrong S; Höltje M; Just I; Bandtlow C; Klimaschewski L
    Front Cell Neurosci; 2012; 6():43. PubMed ID: 23087613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mevalonate Cascade and Small Rho GTPase in Spinal Cord Injury.
    Eftekharpour E; Nagakannan P; Iqbal MA; Chen QM
    Curr Mol Pharmacol; 2017; 10(2):141-151. PubMed ID: 26758952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROCK inhibition enhances neurite outgrowth in neural stem cells by upregulating YAP expression in vitro.
    Jia XF; Ye F; Wang YB; Feng DX
    Neural Regen Res; 2016 Jun; 11(6):983-7. PubMed ID: 27482229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-glycan antibodies halt axon regeneration in a model of Guillain Barrè Syndrome axonal neuropathy by inducing microtubule disorganization via RhoA-ROCK-dependent inactivation of CRMP-2.
    Rozés Salvador V; Heredia F; Berardo A; Palandri A; Wojnacki J; Vivinetto AL; Sheikh KA; Caceres A; Lopez PH
    Exp Neurol; 2016 Apr; 278():42-53. PubMed ID: 26804001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.